GL1X · GenesisL1 explorer

Research workbench

High resolution HIV-2 protease structure in complex with antiviral inhibitor grl-98065

Analyse High resolution HIV-2 protease structure in complex with antiviral inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ECG
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.47
UniProt
P04584
Ligands
065, ZN, NA, CL
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.47)protein996% helix, 55% strandP04584

Ligands and binding sites

  • 065 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(2s,3r)-3-hydroxy-4-(N-isobutylbenzo[d][1,3]dioxole-5-sulfonamido)-1-phenylbutan-2-ylcarbamate · ligand · chains A, B
  • ZN · Zinc ion · metal · 11 copies · chains A, B
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · 9 copies · chains A, B
  • IMD · Imidazole · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13230.710.8434065, CL

Interfaces

1 interface between chains.

  • A–B · 1764 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 3ECG · High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-98065 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.